Pharmala Biotech Holdings Inc. (CSE:MDMA)

Pharmala Biotech Holdings Statistics

Total Valuation

CSE:MDMA has a market cap or net worth of CAD 11.43 million. The enterprise value is 10.53 million.

Market Cap	11.43M
Enterprise Value	10.53M

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

CSE:MDMA has 108.89 million shares outstanding. The number of shares has increased by 15.10% in one year.

Current Share Class	108.89M
Shares Outstanding	108.89M
Shares Change (YoY)	+15.10%
Shares Change (QoQ)	+9.04%
Owned by Insiders (%)	9.27%
Owned by Institutions (%)	n/a
Float	98.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.15
PB Ratio	4.82
P/TBV Ratio	18.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.00
EV / Sales	13.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.40

Financial Position

The company has a current ratio of 1.60

Current Ratio	1.60
Quick Ratio	1.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -98.51% and return on invested capital (ROIC) is -55.94%.

Return on Equity (ROE)	-98.51%
Return on Assets (ROA)	-39.68%
Return on Invested Capital (ROIC)	-55.94%
Return on Capital Employed (ROCE)	-80.68%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.25
Inventory Turnover	0.25

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.54% in the last 52 weeks. The beta is 0.77, so CSE:MDMA's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-61.54%
50-Day Moving Average	0.11
200-Day Moving Average	0.12
Relative Strength Index (RSI)	46.45
Average Volume (20 Days)	153,892

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:MDMA had revenue of CAD 754,641 and -2.11 million in losses. Loss per share was -0.02.

Revenue	754,641
Gross Profit	666,642
Operating Income	-1.91M
Pretax Income	-2.11M
Net Income	-2.11M
EBITDA	-1.88M
EBIT	-1.91M
Loss Per Share	-0.02

Balance Sheet

The company has 901,384 in cash and n/a in debt, with a net cash position of 901,384 or 0.01 per share.

Cash & Cash Equivalents	901,384
Total Debt	n/a
Net Cash	901,384
Net Cash Per Share	0.01
Equity (Book Value)	2.37M
Book Value Per Share	0.02
Working Capital	617,558

Cash Flow

In the last 12 months, operating cash flow was -921,029 and capital expenditures -2,918, giving a free cash flow of -923,947.

Operating Cash Flow	-921,029
Capital Expenditures	-2,918
Free Cash Flow	-923,947
FCF Per Share	-0.01

Margins

Gross margin is 88.34%, with operating and profit margins of -253.55% and -279.05%.

Gross Margin	88.34%
Operating Margin	-253.55%
Pretax Margin	-279.05%
Profit Margin	-279.05%
EBITDA Margin	-248.65%
EBIT Margin	-253.55%
FCF Margin	n/a

Dividends & Yields

CSE:MDMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.10%
Shareholder Yield	-15.10%
Earnings Yield	-18.42%
FCF Yield	-8.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSE:MDMA has an Altman Z-Score of 5.15 and a Piotroski F-Score of 3.

Altman Z-Score	5.15
Piotroski F-Score	3